arrow_back Back to App

Insulin Price Cap: Manufacturers Limited to $20 Per 1000 Units.

This bill establishes a fixed price ceiling for insulin sold by manufacturers in the United States. Manufacturers would be prohibited from charging more than $20 per 1000 units of insulin, regardless of the delivery method. This change aims to significantly reduce the financial burden of diabetes treatment for millions of citizens, improving access to this life-saving medication.
Key points
Sets a maximum price for insulin at $20 per 1000 units, directly lowering treatment costs for consumers.
The price limit applies to manufacturers and covers all forms of insulin delivery (vials, pens, cartridges).
The goal is to ensure greater financial accessibility to this essential drug for individuals with diabetes.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_727
Sponsor: Sen. Sanders, Bernard [I-VT]
Process start date: 2023-03-09
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Insulin for All Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_727.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-03-09.

What are the main provisions?

Key points include:

  • Sets a maximum price for insulin at $20 per 1000 units, directly lowering treatment costs for consumers.
  • The price limit applies to manufacturers and covers all forms of insulin delivery (vials, pens, cartridges).
  • The goal is to ensure greater financial accessibility to this essential drug for individuals with diabetes.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Sanders, Bernard [I-VT].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health Economy